Howard Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
HCM
AAMU
FWCM
AAIS
Howard Wealth Management's ABBV Position: Q2 2026 in Review
Howard Wealth Management reduced its AbbVie (ABBV) stake by 37% in Q2 2026, selling an estimated $134K and leaving 1,064 shares worth $268K. The position accounts for 0.1% of the portfolio, ranked #128.
Howard Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 23 quarters since. The position peaked at $411K in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Howard Wealth Management held 1,064 shares of AbbVie worth $268K as of Q2 2026.
- Howard Wealth Management sold 622 AbbVie shares in Q2 2026, an estimated $134K.
- AbbVie made up 0.1% of Howard Wealth Management's portfolio in Q2 2026, its #128 holding.
- Howard Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 23 quarters since.
- Howard Wealth Management's AbbVie position peaked at $411K in Q3 2025.
- 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Howard Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.